Filing Details

Accession Number:
0001477932-23-002273
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-05 16:15:42
Reporting Period:
2023-04-03
Accepted Time:
2023-04-05 16:15:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1443863 Biocorrx Inc. BICX Services-Specialty Outpatient Facilities, Nec (8093) 900967447
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1539788 C. Louis Lucido 2390 East Orangewood Avenue
Suite 500
Anaheim CA 92806
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2023-04-03 171,296 $1.75 276,279 No 4 P Indirect By Trust
Common Stock, Par Value $0.001 Acquisiton 2023-04-03 183,606 $0.00 459,885 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 J Direct
Footnotes
  1. These shares were issued to the Louis C Lucido and Carolyn M. Lucido, or their Successors, as Trustee of the Lucido Family Trust, Dated May 23, 2017, managed by Mr. Louis C Lucido (the "Lucido Trust") pursuant to a subscription agreement by and between BioCorRx Inc. and the Lucido Trust dated March 29 2023, and paid for on April 3, 2023. The Reporting Person may be deemed to have investment power over the Lucido Trust.
  2. These shares were issued to Mr. Lucido pursuant to an exchange agreement by and between BioCorRx Inc. (the "Company") and Mr. Lucido dated April 3, 2023 (the "Exchange Agreement"). Pursuant to the Exchange Agreement, the Company agreed to issue 183,606 shares of its common stock, par value $0.001 per share, to Mr. Lucido and Mr. Lucido agreed to exchange, surrender and cancel that certain promissory note dated November 1, 2022 held by Mr. Lucido in the aggregate amount of $313,892, including interest.